| Literature DB >> 24752411 |
Linhui Hao1, Brett Lindenbach2, Xiaofeng Wang2, Billy Dye2, David Kushner2, Qiuling He3, Michael Newton4, Paul Ahlquist5.
Abstract
Flock House virus (FHV), the best studied of the animal nodaviruses, has been used as a model for positive-strand RNA virus research. As one approach to identify host genes that affect FHV RNA replication, we performed a genome-wide analysis using a yeast single gene deletion library and a modified, reporter gene-expressing FHV derivative. A total of 4,491 yeast deletion mutants were tested for their ability to support FHV replication. Candidates for host genes modulating FHV replication were selected based on the initial genome-wide reporter gene assay and validated in repeated Northern blot assays for their ability to support wild type FHV RNA1 replication. Overall, 65 deletion strains were confirmed to show significant changes in the replication of both FHV genomic RNA1 and sub-genomic RNA3 with a false discovery rate of 5%. Among them, eight genes support FHV replication, since their deletion significantly reduced viral RNA accumulation, while 57 genes limit FHV replication, since their deletion increased FHV RNA accumulation. Of the gene products implicated in affecting FHV replication, three are localized to mitochondria, where FHV RNA replication occurs, 16 normally reside in the nucleus and may have indirect roles in FHV replication, and the remaining 46 are in the cytoplasm, with functions enriched in translation, RNA processing and trafficking.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24752411 PMCID: PMC3994138 DOI: 10.1371/journal.pone.0095799
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Structure, plasmid-directed synthesis and replication of wt FHV RNA1 and Renilla luciferase-expressing derivative F1R.
A) Diagram of FHV RNA1 expression plasmid pF1, which uses the galactose-inducible, glucose-repressible GAL1 promoter to express a wt FHV RNA1 transcript whose 3′ end is formed by self-cleavage by a hepatitis delta virus ribozyme [48]. RNA1 is translated to produce protein A, the multifunctional FHV RNA synthesis protein, which directs RNA1 replication and, through a truncated negative-strand intermediate ((-) sgRNA3), production and subsequent replication of RNA3 (sgRNA3), a subgenomic mRNA that encodes two ORFs: B1, the C-terminus of protein A, and B2, an RNA silencing suppressor. B). Plasmid pFA is a pF1 derivative that retains the complete FHV protein A ORF but has the FHV 5′ and 3′ untranslated regions, which contain essential cis-acting RNA replication signals, replaced with nonviral sequences. The resulting transcript from the pFA GAL1 promoter translates full length, wt FHV protein A, but cannot serve as an RNA replication template. Plasmid pF1R is a second pF1 derivative that retains the full length RNA1 sequence, but bears an early frameshift mutation in the protein A ORF and an insertion of the Renilla luciferase ORF immediately after the initiation codon of the B1 ORF AUG in RNA3. The resulting pF1R transcript thus cannot translate protein A but, when protein A is provided in trans from pFA, is replicated and produces a Renilla luciferase-expressing subgenomic RNA3 derivative.
Figure 2Validation of FHV replication-dependent luciferase expression.
Yeasts transformed with the indicated plasmids were assayed for luciferase activity. As shown, significant luciferase activity was only observed when there is active FHV RNA replication and subgenomic mRNA synthesis, which depend on expressing both functional protein A (expressed from pFA) and a functional FHV RNA1 derived template RNA (from pF1R). Neither protein A (pFA) alone, nor the RNA1 derived template RNA (pF1R) alone produced luciferase activity above background. The need for FHV RNA synthesis is further demonstrated by the effects of a polymerase-inactivating mutation in the protein A active site (expressed from pFA(GED)), which reduces luciferase activity to background level even when expressed together with pF1R.
Figure 3FHV RNA1 replication in selected yeast deletion mutants.
Yeast strains with the indicated gene deletions were transformed with plasmid pF1 (Figure 1A) and, following galactose-induction of pF1 transcription, FHV genomic RNA1 replication and subgenomic RNA3 production were assayed by Northern blot hybridization. The histograms show the averages and standard deviations of RNA1 and RNA3 levels across four independent experiments. Representative Northern blots are shown above each histogram. A). FHV wild type RNA1 replication in all 8 deletion mutants whose deleted gene functions facilitate FHV replication. WT denotes the no deletion control. B). FHV wild type RNA1 replication in a selected subsets of yeast deletion mutants whose deleted gene functions normally inhibit FHV replication. Accordingly, these strains show increased FHV replication.
Yeast genes that support FHV replication.
| Mitochondrial | ||||||||
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
| YPL183W-A | structural constituent of ribosome | 67% | −5.1 | 1.7% | 65% | −3.5 | 4.5% | |
| Metabolism | ||||||||
| YOL071W | SDH5 | oxidoreductase activity | 59% | −6.0 | 1.5% | 34% | −3.5 | 4.4% |
| YKL148C | SDH1 | oxidoreductase activity | 32% | −13.8 | 0.6% | 6% | −41.0 | 0.2% |
| YPL037C | EGD1 | unfolded protein binding | 42% | −41.5 | 0.3% | 32% | −44.6 | 0.2% |
|
| ||||||||
|
| ||||||||
| YLR410W | VIP1 | inositol phosphate kinase | 27% | −23.3 | 0.3% | 10% | −34.0 | 0.2% |
|
| ||||||||
| YOL045W | PSK2 | protein serine/threonine kinase activity | 37% | −12.7 | 0.6% | 14% | −10.5 | 2.0% |
| YKL116C | PRR1 | receptor signaling protein serine/threonine kinase activity | 23% | −29.3 | 0.3% | 5% | −14.8 | 1.1% |
|
| ||||||||
| YOR083W | WHI5 | specific transcriptional repressor activity | 32% | −20.7 | 0.3% | 22% | 5.8 | 2.7% |
Yeast genes that suppress FHV replication.
| Nucleus | ||||||||
| ORF | Gene | Molecular Function | RNA1 (%WT) | t1 | q1 | RNA3 (%WT) | t3 | q3 |
|
| ||||||||
| YDR295C | HDA2 | histone deacetylase activity | 572% | 5.6 | 1.5% | 735% | 4.58 | 3.2% |
| YNL059C | ARP5 | structural molecule activity | 564% | 8.8 | 0.8% | 924% | 7.47 | 2.2% |
| YJL115W | ASF1 | histone binding | 413% | 21.3 | 0.3% | 604% | 22.00 | 0.6% |
| YER040W | GLN3 | metal ion binding | 389% | 10.0 | 0.7% | 330% | 3.21 | 4.7% |
| YLR226W | BUR2 | cyclin-dependent protein kinase regulator activity | 358% | 5.8 | 1.5% | 347% | 6.20 | 2.6% |
| YML036W | CGI121 | molecular_function unknown | 226% | 5.7 | 1.5% | 277% | 3.62 | 4.3% |
| YEL009C | GCN4 | DNA binding | 201% | 5.7 | 1.5% | 259% | 10.02 | 2.0% |
| YDL115C | IWR1 | molecular_function unknown | 511% | 5.2 | 1.6% | 695% | 3.97 | 4.0% |
|
| ||||||||
| YEL044W | IES6 | molecular_function unknown | 372% | 7.3 | 1.0% | 759% | 5.12 | 2.9% |
| YJL127C | SPT10 | sequence-specific DNA binding | 362% | 7.2 | 1.0% | 446% | 3.92 | 4.0% |
|
| ||||||||
| YDR369C | XRS2 | DNA binding | 283% | 4.0 | 2.5% | 326% | 3.40 | 4.6% |
|
| ||||||||
| YAL024C | LTE1 | guanyl-nucleotide exchange factor activity | 453% | 11.4 | 0.6% | 873% | 7.78 | 2.2% |
| YHR191C | CTF8 | molecular_function unknown | 416% | 7.7 | 0.9% | 477% | 4.83 | 3.1% |
| YPL008W | CHL1 | nucleotide binding | 289% | 20.0 | 0.3% | 448% | 5.58 | 2.8% |
| #YPR046W | MCM16 | protein binding | 276% | 7.0 | 1.1% | 389% | 3.13 | 4.8% |
| YMR014W | BUD22 | molecular_function unknown | 566% | 8.8 | 0.8% | 901% | 6.20 | 2.6% |
|
| ||||||||
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
| YDR025W | RPS11A | structural constituent of ribosome | 677% | 5.2 | 1.6% | 637% | 3.85 | 4.0% |
| YLR441C | RPS1A | structural constituent of ribosome | 593% | 5.8 | 1.5% | 1043% | 3.74 | 4.1% |
| YKL006W | RPL14A | structural constituent of ribosome | 585% | 17.5 | 0.4% | 691% | 7.90 | 2.2% |
| YGR027C | RPS25A | structural constituent of ribosome | 484% | 6.9 | 1.1% | 584% | 5.09 | 2.9% |
|
| RPL7A | structural constituent of ribosome | 431% | 9.0 | 0.8% | 628% | 5.96 | 2.7% |
| YNL069C | RPL16B | structural constituent of ribosome | 342% | 21.7 | 0.3% | 661% | 10.11 | 2.0% |
| YMR142C | RPL13B | structural constituent of ribosome | 310% | 7.6 | 0.9% | 414% | 4.24 | 3.6% |
| YMR143W | RPS16A | structural constituent of ribosome | 299% | 7.7 | 0.9% | 306% | 5.19 | 2.9% |
| YMR230W | RPS10B | structural constituent of ribosome | 239% | 4.2 | 2.3% | 293% | 4.35 | 3.6% |
| YPR132W | RPS23B | structural constituent of ribosome | 229% | 6.6 | 1.2% | 332% | 9.30 | 2.2% |
| YDL083C | RPS16B | structural constituent of ribosome | 212% | 13.5 | 0.6% | 333% | 3.92 | 4.0% |
| YBL072C | RPS8A | structural constituent of ribosome | 209% | 7.6 | 0.9% | 322% | 7.43 | 2.2% |
|
| ||||||||
| YOL041C | NOP12 | RNA binding | 244% | 7.0 | 1.1% | 364% | 3.11 | 4.9% |
| YGR159C | NSR1 | nucleotide binding | 571% | 11.1 | 0.6% | 644% | 5.05 | 2.9% |
| YKL009W | MRT4 | mRNA turn over and ribosome assmebly | 558% | 3.2 | 3.8% | 853% | 3.05 | 5.0% |
| #YOR076C | SKI7 | 3′-5′ exonuclease activity | 309% | 17.2 | 0.4% | 343% | 5.47 | 2.8% |
| #YLR398C | SKI2 | RNA helicase activity | 335% | 7.6 | 0.9% | 339% | 5.84 | 2.7% |
| #YPR189W | SKI3 | translation repressor activity | 254% | 8.7 | 0.8% | 324% | 5.53 | 2.8% |
| YHR081W | LRP1 | nuclear exosome (RNase complex) | 336% | 11.9 | 0.6% | 433% | 7.28 | 2.2% |
| YPL213W | LEA1 | RNA splicing factor activity, transesterification mechanism | 887% | 3.9 | 2.6% | 1119% | 3.47 | 4.5% |
| #YCR063W | BUD31 | RNA splicing | 194% | 3.0 | 4.5% | 152% | 3.32 | 4.7% |
| YPL157W | TGS1 | transferase activity | 584% | 19.2 | 0.3% | 981% | 4.42 | 3.5% |
|
| ||||||||
| #YLR373C | VID22 | vacuola transport | 381% | 9.5 | 0.7% | 569% | 4.89 | 3.0% |
| YPR139C | VPS66 | vacuola protein sorting | 380% | 6.5 | 1.2% | 741% | 4.32 | 3.6% |
|
| VPS24 | protein binding | 369% | 5.1 | 1.7% | 585% | 3.77 | 4.1% |
| YLR360W | VPS38 | late endosome to vacuola transport | 340% | 10.4 | 0.7% | 461% | 7.53 | 2.2% |
| YGL023C | PIB2 | metal ion binding | 312% | 5.4 | 1.6% | 283% | 4.17 | 3.6% |
| YDR320C | SWA2 | protein binding | 505% | 8.3 | 0.9% | 651% | 6.47 | 2.6% |
| YPL195W | APL5 | protein binding | 220% | 8.2 | 0.9% | 246% | 17.99 | 0.7% |
| YDR276C | PMP3 | cation transport | 166% | 7.3 | 1.0% | 204% | 11.25 | 2.0% |
| #YPL226W | NEW1 | nucleotide binding, ATPase | 200% | 7.9 | 0.9% | 214% | 3.37 | 4.6% |
|
| ||||||||
| YJR032W | CPR7 | chaperone activity | 320% | 6.4 | 1.3% | 438% | 3.23 | 4.7% |
|
| ||||||||
| YDR226W | ADK1 | nucleotide binding | 430% | 6.1 | 1.4% | 663% | 5.86 | 2.7% |
| YML022W | APT1 | transferase activity | 208% | 3.5 | 3.3% | 267% | 5.09 | 2.9% |
| YPL017C | IRC15 | oxidoreductase activity | 238% | 11.3 | 0.6% | 386% | 7.90 | 2.2% |
| YHR204W | MNL1 | hydrolase activity | 299% | 5.0 | 1.7% | 313% | 5.08 | 2.9% |
|
| ||||||||
| YOR080W | DIA2 | SCF ubiquitin ligase complex | 277% | 4.4 | 2.2% | 575% | 4.22 | 3.6% |
| YMR116C | ASC1 | signal transducer activity | 593% | 10.8 | 0.6% | 760% | 5.17 | 2.9% |
|
| ||||||||
| YOR235W | IRC13 | 427% | 10.2 | 0.7% | 613% | 6.563 | 2.6% | |
| YLR232W | 302% | 9.2 | 0.7% | 314% | 7.875 | 2.2% | ||
| #YDR241W | BUD26 | bud site selection | 515% | 12.6 | 0.6% | 981% | 8.393 | 2.2% |
#Genes also identified to affect BMV replication.
*Genes also identified to affect TBSV replication.
Figure 4Genes in the Ski pathway normally suppress FHV replication in yeast.
Yeast strains with the indicated Ski gene deletions were transformed with plasmid pF1 (Figure 1A) and, following galactose-induction of pF1 transcription, FHV genomic RNA1 replication and subgenomic RNA3 production were assayed by Northern blot hybridization. The histograms show the averages and standard deviations of RNA1 and RNA3 levels across four independent experiments. Representative Northern blots are shown above the histograms.